Table 2.

Immune function of patients in three groups

	VZV encephalitis/meningitis group (n=32)	Herpes zoster group (n=129)	Control group (n=31)	F	P
CD3+ (×109/L)	0.78±0.42*,#	1.04±0.43*	1.23±0.41	9.055	0.000
CD19+ (×109/L)	0.17±0.12	0.21±0.13	0.24±0.17	1.712	0.183
CD4+ (×109/L)	0.44±0.26*,#	0.58±0.27*	0.76±0.30	10.760	0.000
CD8+ (×109/L)	0.30±0.17#	0.41±0.21	0.40±0.21	3.958	0.021
CD4+/CD8+	1.77±1.07	1.63±0.82*	2.36±1.61	6.456	0.002
CD56+ (×109/L)	0.20±0.10	0.25±0.16	0.26±0.18	1.340	0.264
C3 (g/L)	1.21±0.27	1.30±0.97	1.11±0.23	0.710	0.491
C4 (g/L)	0.40±0.14	0.41±0.28	0.40±0.15	0.020	0.985
IgA (g/L)	2.44±1.03	2.35±1.00	2.10±0.88	1.007	0.367
IgG (g/L)	11.39±3.20	11.75±2.74	12.04±3.02	0.346	0.708
IgM (g/L)	1.01±0.47	1.11±0.57	0.89±0.54	1.910	0.151

Note: VZV: Varicella-Zoster Virus; C3: Complements 3; C4: Complements 4; IgA: Immunoglobulin A; IgG: Immunoglobulin G; IgM: Immunoglobulin M.

^*P<0.05 vs control group;

^#P<0.05 vs herpes zoster group.